(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 1.04% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 36.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.77%.
Perrigo Co's revenue in 2026 is $4,281,800,000.On average, 6 Wall Street analysts forecast PRGO's revenue for 2026 to be $585,452,534,286, with the lowest PRGO revenue forecast at $550,083,163,973, and the highest PRGO revenue forecast at $610,362,479,915. On average, 6 Wall Street analysts forecast PRGO's revenue for 2027 to be $593,434,726,808, with the lowest PRGO revenue forecast at $558,340,604,513, and the highest PRGO revenue forecast at $624,400,128,833.
In 2028, PRGO is forecast to generate $609,674,359,870 in revenue, with the lowest revenue forecast at $578,158,461,809 and the highest revenue forecast at $635,685,297,571.